Merki-Feld Gabriele S, Gruber Isabel M L
Division of Reproductive Endocrinology, University Hospital, Zurich, Switzerland.
Eur J Contracept Reprod Health Care. 2012 Apr;17(2):119-27. doi: 10.3109/13625187.2011.630114. Epub 2011 Dec 27.
Considering the advantages of parenteral routes of administration of combined hormonal contraceptives (CHCs), their low prevalence of use in Europe is surprising. The Contraceptive health research of informed choice experience (CHOICE) study involved 11 European countries. It aimed at evaluating the influence of counselling on users' choice between three modalities of CHC administration (the pill, the transdermal patch, and the vaginal ring). We report here the results for Switzerland.
Women (N = 2629) with a need for contraception received extended counselling. Questionnaires were used to collect data about the women's preferred method before and after counselling, and the reasons for their ultimate decision.
After counselling, 40% of the women chose a contraceptive method that was different from the one initially intended. The number of vaginal ring users (28% vs. 11% intended) and patch users (7% vs. 4% intended) increased (p < 0.0001). Of the initially undecided women, 93% chose a contraceptive method after counselling. However, although information was provided on the risks, side effects and benefits associated with the different contraceptive methods, surprisingly few women retained this knowledge.
The provision of balanced information on all CHCs influenced women's decisions to a great extent. Unlike the pill, non-oral methods were significantly more often chosen.
考虑到复方激素避孕药(CHCs)非肠道给药途径的优势,其在欧洲的低使用率令人惊讶。避孕知情选择经验健康研究(CHOICE)涉及11个欧洲国家。其旨在评估咨询对使用者在三种CHC给药方式(药片、透皮贴剂和阴道环)之间选择的影响。我们在此报告瑞士的研究结果。
有避孕需求的女性(N = 2629)接受了详细咨询。通过问卷收集咨询前后女性首选方法的数据以及她们最终决定的原因。
咨询后,40%的女性选择了与最初打算的不同的避孕方法。阴道环使用者数量(预期为11%,实际为28%)和透皮贴剂使用者数量(预期为4%,实际为7%)增加(p < 0.0001)。在最初未做决定的女性中,93%在咨询后选择了一种避孕方法。然而,尽管提供了不同避孕方法相关的风险、副作用和益处的信息,但令人惊讶的是,很少有女性记住这些知识。
提供关于所有CHCs的平衡信息在很大程度上影响了女性的决定。与药片不同,非口服方法被选择的频率明显更高。